Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZLHQ-5f is a dual inhibitor of CDK2 and Topo I, acting on CDK2/CycA2 (IC50: 0.145 μM). ZLHQ-5f has a good safety profile by blocking the cell cycle of HCT116 cells in S phase and inducing apoptosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.444 € | 10-14 weeks | |
50 mg | 1.881 € | 10-14 weeks | |
100 mg | 2.375 € | 10-14 weeks |
Description | ZLHQ-5f is a dual inhibitor of CDK2 and Topo I, acting on CDK2/CycA2 (IC50: 0.145 μM). ZLHQ-5f has a good safety profile by blocking the cell cycle of HCT116 cells in S phase and inducing apoptosis. |
Molecular Weight | 463.53 |
Formula | C28H25N5O2 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.